BCO Pharma is a late development stage healthcare company that develops products for the unique needs of pediatric or other vulnerable patient populations. The company's lead product is a unique pediatric formulation of an inotrope that is used to treat hypotension in critically ill babies and children. The phase III trial supporting the product is now finished and an application for a marketing authorization in the EU will be submitted in August of 2022.
Company Details
- Employees
- 1
- Founded
- -
- Address
- Bank House, Cork,ireland
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- bcopharma.com
- Keywords
- IT Consulting.
- HQ
- Cork
Bco Pharma Questions
Bco Pharma's website is bcopharma.com
Bco Pharma's LinkedIn profile is https://ie.linkedin.com/company/bco-pharma
Bco Pharma has
1 employees.
View email and phone details for 1
employees at Bco Pharma.
Bco Pharma's industry is
Pharmaceutical Manufacturing
Bco Pharma's top competitors are
Anabio Technologies,
Alvarius,
Eirgen Pharma,
Chanelle Pharma,
Azure Pharmaceuticals Ltd.,
Qrtraining,
Alvarius Pharmaceuticals,
Wyntra Pharmaceuticals,
Kent-Athlone Pharma Group,
Norbrook Laboratories Ltd.
Bco Pharma's categories are Pharmaceutical Manufacturing
Bco Pharma's founding year is 2009
